Administration of extracellular vesicles derived from human amniotic fluid stem cells: a new treatment for necrotizing enterocolitis

Keyphrases

• Necrotizing Enterocolitis 100%
• Adipose-derived Mesenchymal Stem Cells (ADMSCs) 100%
• Extracellular Vesicles 100%
• Phosphate-buffered Saline 30%
• Cell Proliferation 20%
• Cellular Expression 20%
• C57BL 10%
• Postnatal Day 10%
• Placebo 10%
• Inflammation 10%
• Breast 10%
• Stem Cells 10%
• Ki-67 10%
• Intestinal Inflammation 10%
• Terminal Ileum 10%
• Beneficial Effects 10%
• Gastrointestinal Diseases 10%
• Hypoxia 10%
• Intraperitoneal Injection 10%
• Conditioned Medium 10%
• Lipopolysaccharide 10%
• Intestinal Stem Cells 10%
• Feed Control 10%
• California USA 10%
• Lgr5+ 10%
• Amniotic Fluid Stem Cells 10%
• Intestinal Injury 10%
• Human Translation 10%
• Exogenous Stem Cells 10%
• Gavage Feeding 10%

Medicine and Dentistry

• Necrotizing Enterocolitis 100%
• Amniotic Stem Cell 100%
• Phosphate Buffered Saline 30%
• Cell Proliferation 20%
• Stem Cell 20%
• C57BL/6 10%
• Tumor Necrosis Factor 10%
• Placebo 10%
• Intestine Injury 10%
• Terminal Ileum 10%
• Intraperitoneal Drug Administration 10%
• Enteritis 10%
• Hypoxia 10%
• Gastrointestinal Disease 10%
• Lipopolysaccharide 10%
• Intestinal Stem Cell 10%
• Feeding 10%

Immunology and Microbiology

• Enterocolitis 100%
• Amniotic Fluid Stem Cell 100%
• Stem Cell 20%
• Cell Proliferation 20%
• Tumor Necrosis Factor 10%
• Enteritis 10%
• Intestinal Stem Cell 10%
• Terminal Ileum 10%